JP2001513566A5 - - Google Patents

Download PDF

Info

Publication number
JP2001513566A5
JP2001513566A5 JP2000507383A JP2000507383A JP2001513566A5 JP 2001513566 A5 JP2001513566 A5 JP 2001513566A5 JP 2000507383 A JP2000507383 A JP 2000507383A JP 2000507383 A JP2000507383 A JP 2000507383A JP 2001513566 A5 JP2001513566 A5 JP 2001513566A5
Authority
JP
Japan
Prior art keywords
estrogen
combination
progestin
days
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2000507383A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001513566A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/017288 external-priority patent/WO1999009993A1/en
Publication of JP2001513566A publication Critical patent/JP2001513566A/ja
Publication of JP2001513566A5 publication Critical patent/JP2001513566A5/ja
Ceased legal-status Critical Current

Links

JP2000507383A 1997-08-27 1998-08-20 経口避妊における、エストロゲンと子宮内膜節約性プロゲスチンおよび子宮内膜萎縮性プロゲスチンとの組み合わせ物 Ceased JP2001513566A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5710997P 1997-08-27 1997-08-27
US60/057,109 1997-08-27
PCT/US1998/017288 WO1999009993A1 (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Publications (2)

Publication Number Publication Date
JP2001513566A JP2001513566A (ja) 2001-09-04
JP2001513566A5 true JP2001513566A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=22008560

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000507383A Ceased JP2001513566A (ja) 1997-08-27 1998-08-20 経口避妊における、エストロゲンと子宮内膜節約性プロゲスチンおよび子宮内膜萎縮性プロゲスチンとの組み合わせ物

Country Status (9)

Country Link
EP (1) EP1007052B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001513566A (cg-RX-API-DMAC7.html)
AT (1) ATE279198T1 (cg-RX-API-DMAC7.html)
AU (1) AU9028098A (cg-RX-API-DMAC7.html)
DE (1) DE69827017T2 (cg-RX-API-DMAC7.html)
DK (1) DK1007052T3 (cg-RX-API-DMAC7.html)
ES (1) ES2230711T3 (cg-RX-API-DMAC7.html)
PT (1) PT1007052E (cg-RX-API-DMAC7.html)
WO (1) WO1999009993A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
AU2004277998A1 (en) * 2003-10-01 2005-04-14 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
EP1535618A1 (en) 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
DE4104385C1 (cg-RX-API-DMAC7.html) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Similar Documents

Publication Publication Date Title
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
AR029159A1 (es) Preparacion farmaceutica, envase que la contiene y uso en la preparacion de un medicamento util en la terapia de reemplazo hormonal
WO2001064182A3 (en) Improvements in or relating to the delivery of oral drugs
ES2175650T3 (es) Anticonceptivos orales de dosis ultra baja con menos hemorragia menstrual y eficacia mantenida.
CA2240329A1 (en) Improved delivery of multiple doses of medications
AR031563A1 (es) Una composicion farmaceutica para emplear en el tratamiento de trastornos menopausicos o posmenopausicos de estrogenos y acetato de medroxiprogesterona, una unidad de dosificacion farmaceutica y uso de una combinacion de estrogenos conjugados y acetato de medroxiprogesterona para la manufactura de u
RU2001129160A (ru) Прерывистая гормонозаместительная терапия низкими дозами эстрогена
JP2004508398A5 (cg-RX-API-DMAC7.html)
JP2002524415A5 (cg-RX-API-DMAC7.html)
DE59205986D1 (de) Ovulationshemmendes Mittel zur hormonalen Kontrazeption
CO5261567A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas
MY128482A (en) New hormonal composition and its use
JP2002540148A5 (cg-RX-API-DMAC7.html)
PL348202A1 (en) Pharmaceutically active composition and dispensing device
JP2003509467A5 (cg-RX-API-DMAC7.html)
RU2002111000A (ru) Способ терапевтического лечения внематочной пролиферации эндометриальной ткани, хронической боли в области таза и непроходимости фаллопиевых труб, фармацевтическая композиция и анатагонист LHRH-лекарственное средство для указанного лечения (варианты)
ES2590914T3 (es) Preparación hormonal que contiene una combinación de etinilestradiol y acetato de clormadinona
JP2003523385A5 (cg-RX-API-DMAC7.html)
IL126176A0 (en) A pharmaceutical agent containing oestrogen and progesterone for sequential hormone therapy and a packaging unit containing the same
JP2002520269A5 (cg-RX-API-DMAC7.html)
CA2336711A1 (en) Blister containing a transdermal therapeutic system and a single dose form of administration
SI9300687A (en) Transdermal hormone replacement therapy
TH76511A (th) กฎเกณฑ์ และชุดของโพรเจสตินที่เป็นรอบ
SK25299A3 (en) Transdermal therapeutical approach involving a combination of active substances containing oestriol
EP1178807A2 (en) Use of antiprogestagens in combined therapy